Company lists
The Colorado edition · 2026

Life sciencescompanies in Colorado

Research tools, therapeutics, genomics, medical devices, startups and more: the companies building life sciences in Colorado, with their founders, funding, team size and business models.

342 company profiles116 with recorded fundingNovember 2026 edition
Colorado · Photo: Wikimedia Commons (CC BY 4.0)

Recent life sciences business events in Colorado

Funding, M&A, contract wins and launches involving 497 life sciences companies in Colorado, last 24 months: 32 funding rounds · 29 M&A deals · 12 Contracts. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

M&AMerger · Announced

Ignite acquires Ignite Proteomics

The transaction values Ignite at an implied equity value of approximately $150 million, subject to the terms and conditions of the business combination agreement.

Functional proteomics
M&AAcquisition · Announced

Servier acquires Edgewise therapeutics

Servier ... today announced that it has entered into an agreement to acquire the muscular dystrophy business of Edgewise Therapeutics Inc. (Nasdaq: EWTX) ... for up to $2.65 billion,…

Biopharmaceutical
FundingSeries B

Ambrosia biosciences

Ambrosia Biosciences raised $100 million in its Series B funding round, led by Blue Owl, Redmile Group, and Deep Track Capital.

Investors Blue owl, Redmile group, Deep track capital
Biotechnology – Small Molecule
M&AMerger · Completed

Urban-gro acquires Innovative Production Group

urban-gro shares jumped 182% on Monday after the company announced that its merger with Sri Lanka's Innovative Production Group, including its portfolio of T20 league commercial rights,…

M&AMerger · Completed

Urban-gro acquires Flash Sports and Media, Inc.

Urban-gro, Inc. has finalized its merger with Flash Sports and Media, Inc., a U.S.-based company in the sports and media sector.

Sports and media
Funding

Enveda

Enveda raised USD 150m after strong clinical validation of its AI-powered drug discovery platform.

Investors Na
FundingDirect offering

Ocugen

Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced underwritten registered…

Investors Rtw investments
Biotechnology
M&AAcquisition · Completed

Workday acquires Sana

Workday, Inc. (NASDAQ: WDAY), the enterprise AI platform for managing people, money, and agents, announced it has completed its acquisition of Sana, a leading AI company building the…

AI company building enterprise knowledge tools
FundingCredit facility

Viridian therapeutics

Amended Hercules Capital Credit Facility: This amended agreement provides access to capital at Viridian’s discretion upon achievement of certain milestones, extends Viridian’s…

Biopharmaceutical
M&AAcquisition · Announced

TLS Sound Labs acquires Westone laboratories

TLS Sound Labs has acquired Westone Laboratories, marking what the company is calling a new chapter rooted in the company’s original values of quality, service, and care.

Hearing Healthcare
M&AAcquisition · Announced

Cfs technologies acquires Meritech Systems

CFS Technologies, a portfolio company of Union Park Capital, announced the acquisition of Meritech Systems, a Colorado-based manufacturer of fully automated hygiene and sanitation systems.

M&AAcquisition · Announced

Workday acquires Sana

Workday, Inc. (NASDAQ: WDAY) has entered into a definitive agreement to acquire Sana, the Swedish artificial intelligence company known for AI-powered search, agents, and enterprise…

ContractTechnology

Ocugen · client: Kwangdong Pharmaceutical

Ocugen said it executed a licensing agreement with Kwangdong for rights to OCU400, its modifier gene therapy for retinitis pigmentosa.

Biopharma
FundingSeries D

Enveda

Enveda, a clinical-stage biotechnology company developing small-molecule drugs derived from nature’s chemistry, announced the close of a $150 million oversubscribed Series D financing,…

Biotechnology
FundingSeries C

Kromatid

KROMATID, a leader in next-generation genomic structural analysis, today announced the successful close of its Series C funding round, raising a total of $8 million and surpassing its…

Genomic structural analysis
M&AMerger · Announced

Carisma therapeutics acquires Ocugen

On June 22, 2025, Ocugen, Inc. and its subsidiary OrthoCellix, Inc. entered into a merger agreement with Carisma Therapeutics Inc. and its subsidiary, Azalea Merger Sub, Inc.

M&AAcquisition · Completed

Biomet acquires Lanx

Zimmer and Biomet merged in 2015, with Biomet buying spine-tech developer Lanx before the deal and Zimmer Biomet later buying another spine company, LDR.

M&AAcquisition

Zimmer Biomet Holdings acquires Paragon 28

Caitlin Cronin has given her Hold rating due to a combination of factors surrounding Zimmer Biomet Holdings’ recent acquisition of Paragon 28.

M&AAcquisition · Completed

Zimmer biomet acquires Paragon 28

Zimmer Biomet has completed the previously announced acquisition of Paragon 28 for an enterprise value of approximately $1.2bn.

FundingSeries D

Myogen

Myogen Inc. Denver 12/31 $14 Myogen raised another $14M in its Series D financing, bringing the total raised to $66.4M; investors included the Perseus-Soros BioPharmaceutical Fund LP,…

Investors the Perseus-Soros BioPharmaceutical Fund LP, China Development Industrial Bank, Hunt Ventures, Silicon valley bank
Funding

Segetis inc

DSM Venturing, the corporate venturing unit of Royal DSM N.V., has made an equity investment in U.S.-based green chemistry company Segetis Inc.

Investors Dsm venturing, Khosla ventures, Malaysian Life Sciences Capital Fund, managed by Burrill & Co.
Green chemistry
FundingIPO

Array biopharma

Array's underwriters have an option to purchase up to 630,000 additional shares for overallotments. The value, $59M, is based on the Jan. 22 closing stock price.

Investors Lehman brothers, UBS Warburg, Legg Mason Wood Walker Inc., Thomas weisel partners
FundingIPO

Ribozyme pharmaceuticals

Ribozyme Pharmaceuticals Inc. (RZYM) 7/7 1.8S $3.50 $6.3 $5.8 11 $39 HQ (placement agent)

Investors HQ
Funding

Allos therapeutics

Allos Therapeutics Inc. is raising $50 million in much‑needed financing, with proceeds to fund an ongoing Phase III trial of its lead drug candidate, Efaproxyn.

Investors Warburg Pincus Private Equity VIII LP
Biotechnology
FundingSeries A financing

Invenux

Invenux raised $6.7M in a Series A financing supported by Medallion Enterprises LLC and ATP Capital

FundingRegistered direct offering

Ampio pharmaceuticals

Ampio previously raised $25 million in September 2013 in a registered direct offering.

FundingRound

Genicon

Genicon raised $27M in the round; investors included Audax Ventures, CMEA Life Sciences; GIMV and Radius Ventures

Investors Audax Ventures, CMEA Life Sciences, Gimv, Radius Ventures
FundingPublic Offering

Clovis oncology

Clovis Oncology Inc., of Boulder, Colo., said it plans an underwritten public offering of its common shares with a goal of raising approximately $175 million.

Investors J.P. Morgan Securities, BofA Merrill Lynch, Stifel, Suntrust robinson humphrey
Pharmaceuticals

Life sciences companies in Colorado, by funding and team

Few life sciences companies in Colorado publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 342 active companies.

Showing 25 of 50

AI-based platform to decipher the chemistry of nature and develop new medicines

Life sciences tech
US$504.46mSeries D · Sep 2025
383LinkedIn · Oct 2026
Subscription
7 yr2019
0none in 3 months

Developer of gene editing technology for research

Genomics
US$502.33mSeries E · Dec 2022
20+31% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months

Developer of diagnostics assays for the detection of cancer

Pulmonology
US$200.16mSeries F · Dec 2019
361-11% 12 mo to Dec 2023LinkedIn · Oct 2026
Fee-for-service
21 yr2005
0none in 3 months · last posted Jun 2026

Developer of epigenetic therapies for the treatment of cancer.

Oncology
US$195.30mSeries C · Oct 2024
44+9% vs previous recordLinkedIn · Oct 2026
E-commerce - product / Physical commerce
15 yr2011
0none in 3 months · last posted Apr 2026

Developer of genes for pest and disease resistance in plants

Genomics
US$176.00mSeries D · Apr 2008
9+0% 12 mo to Dec 2021LinkedIn · Oct 2026
Subscription
36 yr1990
0none in 3 months

Developer of therapeutics for skeletal and cardiac muscle diseases

Neurology
US$145.00mSeries C · Dec 2020
145+74% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted Feb 2026

Developer of medical-grade wearable devices and data services for patient monitoring

Wearable technology
US$140.05mSeries C · Dec 2025
87-81% vs previous recordLinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted Oct 2025

Developing Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.

Immunotherapy
US$131.81mSeries E · Jun 2014
12-91% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
31 yr1995
0none in 3 months

Developer of small molecule-based therapies for metabolic disorders

Metabolic diseases
US$115.95mSeries B · Mar 2026
38LinkedIn · Jul 2026
E-commerce - product / Physical commerce
2 yr2024
0none in 3 months

Developer of a system for chronic rhinitis treatment via radiofrequency.

Ent disorders
US$110.17mSeries C · Feb 2026
—Not available
Physical commerce
8 yr2018
—No postings tracked

Developer of Osteobiologic products

Orthopedics
US$88.46mSeries D · Jul 2018
192LinkedIn · Jul 2026
Physical commerce
30 yr1996
0none in 3 months · last posted Jun 2026

Early-stage drug delivery company developing Intracerebroventricular (ICV) delivery methods for Valproate for the treatment of neurological diseases such as epilepsy.

Neurology
US$85.80mSeries C · Jun 2022
19-21% vs previous recordrecorded
Fee-for-service
16 yr2010
0none in 3 months

Developer of drug delivery devices to treat cancers

Oncology
US$83.37mSeries D · Mar 2017
132+79% 12 mo to Dec 2021LinkedIn · Oct 2026
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months · last posted Feb 2026

Provider of synthetic biology platform to develop small-molecule therapeutics

Genomics
US$78.00mSeries A · Jan 2026
31+133% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce / Subscription
7 yr2019
0none in 3 months · last posted May 2026

Developer of therapeutics for cancer treatment

Oncology
US$60.00mSeries A · Nov 2022
19LinkedIn · Jul 2026
Subscription
4 yr2022
0none in 3 months

Provider of needle-free injection technology

Drug delivery
US$59.40mSeries B · Oct 2023
32+25% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
21 yr2005
0none in 3 months

Developer of microRNA-based therapeutic solutions for treating multiple diseases

Gene therapy
US$55.67mSeries B · Apr 2012
419LinkedIn · Oct 2026
Physical commerce
19 yr2007
0none in 3 months

Developer of medical devices for treating atrial fibrillation

Cardiac and vascular disorders
US$53.50mSeries B · Dec 2020
9-90% vs previous recordLinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months

Provider of drug discovery platform for the treatment of cancer

Life sciences tech
US$49.48mSeries B · Nov 2025
17+0% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months · last posted Nov 2025

Developer of gene-editing technology

Life sciences platforms and tools
US$48.27mSeries A · Jun 2022
265-1% vs previous recordLinkedIn · Jul 2026
Fee-for-service
8 yr2018
0none in 3 months · last posted Jun 2026

Developer of thermostable vaccines

Life sciences tech
US$46.68mSeries B · Oct 2025
54+100% vs previous recordLinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months · last posted May 2026

Minimally invasive surgical solution for specimen removal, improving patient outcomes

Surgical instruments
US$40.64mSeries A · Mar 2023
14+0% vs previous recordLinkedIn · Jul 2026
Subscription
12 yr2014
0none in 3 months · last posted Aug 2025

Brand of nutrition drinks & supplements

Food & beverage products
US$36.25mSeries A · Jun 2018
15+0% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product
20 yr2006
0none in 3 months · last posted Sep 2025

Developer of endovascular robots

Professional service robots
US$35.00mSeries A · Oct 2025
21LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months · last posted Mar 2026

Developer of an artificial cervical disc for degenerative disc disease

Orthopedics
US$30.41mSeries A · Dec 2024
24LinkedIn · Jul 2026
E-commerce - product / Physical commerce
21 yr2005
0none in 3 months · last posted Oct 2025
50 of 342 companies shown here · the full list is on Radar
Fliar Radar

Explore all 342 life sciences companies in Colorado on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in Colorado on Radar
  • Every company, not just 50All 342 life sciences companies in Colorado, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in Colorado by what you are looking for

Discover top life sciences companies in Colorado spanning research tools, diagnostics, and therapeutics. Explore life sciences startups in Colorado and companies building medical technologies.

7 ways to explore life sciences in Colorado

Life science research tools & platformsOncology & therapeutic development companiesGenomics & diagnostics companiesMedical device & orthopedic companiesLife sciences startups in ColoradoLife sciences companies hiring in Colorado

Life science research tools & platforms

Companies providing scientific tools, instruments, and platforms for research.

  1. Enveda

    AI-based platform to decipher the chemistry of nature and develop new medicines

    Life sciences tech
    See in list
  2. Inscripta

    Developer of gene editing technology for research

    Genomics
    See in list
  3. Arpeggio

    Provider of drug discovery platform for the treatment of cancer

    Life sciences tech
    See in list
  4. VitriVax

    Developer of thermostable vaccines

    Life sciences tech
    See in list
  5. St. Renatus

    Developer of needle-free nasal spray

    Life sciences platforms and tools
    See in list

Oncology & therapeutic development companies

Life sciences companies developing therapies for cancer and other diseases.

  1. Biodesix

    Developer of diagnostics assays for the detection of cancer

    Pulmonology
    See in list
  2. OnKure Therapeutics

    Developer of epigenetic therapies for the treatment of cancer.

    Oncology
    See in list
  3. GlobeImmune

    Developing Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.

    Immunotherapy
    See in list
  4. TriSalus Life Sciences

    Developer of drug delivery devices to treat cancers

    Oncology
    See in list
  5. Nexo Therapeutics

    Developer of therapeutics for cancer treatment

    Oncology
    See in list

Genomics & diagnostics companies

Businesses using genetic, molecular, and diagnostic technologies for health research.

  1. Inscripta

    Developer of gene editing technology for research

    Genomics
    See in list
  2. Evolutionary Genomics

    Developer of genes for pest and disease resistance in plants

    Genomics
    See in list
  3. Think Bioscience

    Provider of synthetic biology platform to develop small-molecule therapeutics

    Genomics
    See in list
  4. MiRagen

    Developer of microRNA-based therapeutic solutions for treating multiple diseases

    Gene therapy
    See in list
  5. Arpeggio

    Provider of drug discovery platform for the treatment of cancer

    Life sciences tech
    See in list

Medical device & orthopedic companies

Developers of orthopedic, surgical, and patient-care medical devices.

  1. NeuroMark Genomics

    Developer of a system for chronic rhinitis treatment via radiofrequency.

    Ent disorders
    See in list
  2. Cerapedics

    Developer of Osteobiologic products

    Orthopedics
    See in list
  3. Ablacon

    Developer of medical devices for treating atrial fibrillation

    Cardiac and vascular disorders
    See in list
  4. Eximis Surgical

    Minimally invasive surgical solution for specimen removal, improving patient outcomes

    Surgical instruments
    See in list
  5. Synergy Spine Solutions

    Developer of an artificial cervical disc for degenerative disc disease

    Orthopedics
    See in list

Life sciences startups in Colorado

Recently founded life sciences companies in Colorado.

  1. Ambrosia Biosciences

    Developer of small molecule-based therapies for metabolic disorders

    Metabolic diseases
    See in list
  2. Nexo Therapeutics

    Developer of therapeutics for cancer treatment

    Oncology
    See in list
  3. Cime Therapeutics

    A biotechnology company focused on advancing drug discovery through a chemistry-first platform

    Life sciences tech
    Website
  4. Perspective Medical

    Developer of medical devices to decrease maternal mortality and morbidity during childbirth

    Women health
    Website
  5. Emet Surgical

    Developer of AI-powered surgical guidance systems. The systems analyze live video feeds during minimally invasive surgery, overlaying crucial information onto the surgeon's monitor. This real-time visual guidance assists with intricate dissections and cancerous tissue identification. The system is designed for ease of use, requiring no additional training for surgeons. It leverages licensed intellectual property for its cancerous tissue recognition engine, providing a "Gross Exam in the OR" capability.

    Surgical instruments
    Website
28 companies in Colorado

Life sciences companies hiring in Colorado

Life sciences employers in Colorado with hiring activity.

  1. Biodesix

    Developer of diagnostics assays for the detection of cancer

    Pulmonology
    See in list
  2. OnKure Therapeutics

    Developer of epigenetic therapies for the treatment of cancer.

    Oncology
    See in list
  3. Edgewise Therapeutics

    Developer of therapeutics for skeletal and cardiac muscle diseases

    Neurology
    See in list
  4. BioIntelliSense

    Developer of medical-grade wearable devices and data services for patient monitoring

    Wearable technology
    See in list
  5. Cerapedics

    Developer of Osteobiologic products

    Orthopedics
    See in list
23 companies in Colorado

Public life sciences companies in Colorado

Listed life sciences companies based in Colorado.

  1. Biodesix

    Developer of diagnostics assays for the detection of cancer

    Pulmonology
    See in list
  2. OnKure Therapeutics

    Developer of epigenetic therapies for the treatment of cancer.

    Oncology
    See in list
  3. Evolutionary Genomics

    Developer of genes for pest and disease resistance in plants

    Genomics
    See in list
  4. Edgewise Therapeutics

    Developer of therapeutics for skeletal and cardiac muscle diseases

    Neurology
    See in list
  5. GlobeImmune

    Developing Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.

    Immunotherapy
    See in list
25 companies in Colorado
Mobile reach

Top 6 life sciences apps from Colorado

The most-installed Android apps published by life sciences companies headquartered in Colorado — 65K installs between them. 6 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 6
1

Proov Fertility & Menopause

by Proov

Installs34K
Rating3.35291 ratings
Last updatedFeb 2026
View on Google Play ↗
Proov Fertility & Menopause screenshot 1Proov Fertility & Menopause screenshot 2Proov Fertility & Menopause screenshot 3Proov Fertility & Menopause screenshot 4Proov Fertility & Menopause screenshot 5Proov Fertility & Menopause screenshot 6
3

Kinobody Fitness

by Kinobody

Installs4K
Rating4.47109 ratings
Last updatedMar 2026
View on Google Play ↗
Kinobody Fitness screenshot 1Kinobody Fitness screenshot 2Kinobody Fitness screenshot 3Kinobody Fitness screenshot 4Kinobody Fitness screenshot 5Kinobody Fitness screenshot 6
RadarBrowse every life sciences company in Colorado on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Colorado compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, Colorado29

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in Colorado

20Acquisition
9Merger

Most active acquirers

  1. Urban-gro4
  2. Zimmer Biomet Holdings3
  3. Workday2
  4. Zimmer biomet2
  5. Ignite1

Most acquired or merged

  1. Paragon 286
  2. Flash Sports & Media, Inc.2
  3. Sana2
  4. Atkins Nutritionals2
  5. Ignite Proteomics1

Each deal appears in the events strip at the top of the page.

Go deeper in the life sciences landscape reports:

Life Sciences Industry Landscape of the United States
Industry landscape report

Life Sciences Industry Landscape of the United States

The financials above are one chapter. The full life sciences landscape of Colorado maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of Colorado

Life sciences funding in Colorado

116 life sciences companies in Colorado have recorded equity funding, US$3.61bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in Colorado

Meet the people behind life sciences companies in Colorado. 231 of 342 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Colorado life sciences companies by sub-sector

The most common specialisations among life sciences companies in Colorado. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in Colorado

185 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in Colorado

Browse the Radar directory

Coming soon